TriSalus Life Sciences Inc
TLSI
Get informed when a big investor buys or sells
+ FollowMarket Cap$154.67M
Close$
$-8.19
303.3% downside
Current Fair Value
303.3% downsideOvervalued by 303.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $154.67 Million |
|---|---|
| Enterprise Value | $132.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.84 |
| Beta | 0.49 |
| Outstanding Shares | 51,539,682 |
Return
| Return on Equity | -451.13% |
|---|---|
| Return on Assets | -81.40% |
| Return on Invested Capital | -46.84% |
Valuation & Multiples
| P/E Ratio | -7.7 |
|---|---|
| PEG | 6.76 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.95 |
| Enterprise Value to EBIT | -4.78 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 2.69 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.16
Average shareholder expectationRevenue Estimate
$10.44 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$10.79 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.44%▲ 17.95% |
|---|---|
| Total Invested | $83.28M▲ 4.58% |
| Investors Holding | 85▲ 21.00% |
ESG Score
No data